2-Hydroxy-5-methyl-3-nitropyridine | CAS:7464-14-4

We serve 2-Hydroxy-5-methyl-3-nitropyridine CAS:7464-14-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Hydroxy-5-methyl-3-nitropyridine

Chemical Name:2-Hydroxy-5-methyl-3-nitropyridine
CAS.NO:7464-14-4
Synonyms:2-Hydroxy-5-methyl-3-nitropyridine
5-methyl-3-nitro-1H-pyridin-2-one
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 334.2±37.0 °C at 760 mmHg
Melting Point 179 °C (dec.)(lit.)
Molecular Formula C6H6N2O3
Molecular Weight 154.123
Flash Point 155.9±26.5 °C
 
Specification:
Appearance:Light yellow solid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-Hydroxy-5-methyl-3-nitropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-methyl-3-nitro-1H-pyridin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-methyl-3-nitro-1H-pyridin-2-one Use and application,5-methyl-3-nitro-1H-pyridin-2-one technical grade,usp/ep/jp grade.


Related News: The Philippines reported its first Wuhan coronavirus fatality on Sunday.1-pyridin-3-ylethanone manufacturer The Philippines reported its first Wuhan coronavirus fatality on Sunday.3,3-Dimethyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone supplier Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.2-Amino-6-fluorobenzoic acid vendor It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.